Peter Manu

4.9k total citations
108 papers, 3.2k citations indexed

About

Peter Manu is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Manu has authored 108 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Psychiatry and Mental health, 21 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Manu's work include Schizophrenia research and treatment (34 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (21 papers) and Diabetes Treatment and Management (15 papers). Peter Manu is often cited by papers focused on Schizophrenia research and treatment (34 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (21 papers) and Diabetes Treatment and Management (15 papers). Peter Manu collaborates with scholars based in United States, Romania and Netherlands. Peter Manu's co-authors include Christoph U. Correll, John M. Kane, Thomas J. Lane, Anne M. Frederickson, Marc D. Binder, Lorena Dima, Dale A. Matthews, Jimmi Nielsen, Davy Vancampfort and Matisyahu Shulman and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Peter Manu

104 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Manu United States 29 2.2k 556 425 421 360 108 3.2k
Jonathan M. Meyer United States 28 2.6k 1.2× 905 1.6× 681 1.6× 154 0.4× 501 1.4× 95 3.7k
Urban Ösby Sweden 33 2.9k 1.3× 409 0.7× 491 1.2× 313 0.7× 495 1.4× 68 5.0k
Daniel E. Casey United States 31 2.8k 1.2× 451 0.8× 683 1.6× 138 0.3× 318 0.9× 73 4.2k
Donna A. Wirshing United States 28 2.4k 1.1× 549 1.0× 552 1.3× 235 0.6× 112 0.3× 50 3.4k
John Lally United Kingdom 27 2.0k 0.9× 223 0.4× 378 0.9× 235 0.6× 180 0.5× 99 3.4k
Ramy Mahmoud United States 32 1.8k 0.8× 247 0.4× 408 1.0× 114 0.3× 174 0.5× 97 3.5k
Beverly N. Jones United States 18 2.4k 1.1× 1.2k 2.2× 993 2.3× 523 1.2× 256 0.7× 23 5.0k
Kim Sweers Belgium 20 1.4k 0.6× 469 0.8× 640 1.5× 99 0.2× 219 0.6× 25 2.2k
Heidi Taipale Finland 38 3.7k 1.7× 282 0.5× 407 1.0× 265 0.6× 415 1.2× 257 5.8k
Katja Komossa Germany 23 3.0k 1.4× 279 0.5× 480 1.1× 173 0.4× 139 0.4× 26 4.3k

Countries citing papers authored by Peter Manu

Since Specialization
Citations

This map shows the geographic impact of Peter Manu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Manu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Manu more than expected).

Fields of papers citing papers by Peter Manu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Manu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Manu. The network helps show where Peter Manu may publish in the future.

Co-authorship network of co-authors of Peter Manu

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Manu. A scholar is included among the top collaborators of Peter Manu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Manu. Peter Manu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manu, Peter, et al.. (2023). Bed Rest After Acute Myocardial Infarction: A Century of Expert Opinions in Cecil Textbook of Medicine. American Journal of Therapeutics. 30(4). e321–e325.
2.
Mitchell, Alex J., Davy Vancampfort, Peter Manu, et al.. (2019). Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study. PLoS ONE. 14(9). e0210674–e0210674. 3 indexed citations
3.
Nielsen, Jimmi, Christoph U. Correll, Peter Manu, & John M. Kane. (2013). Termination of Clozapine Treatment Due to Medical Reasons. The Journal of Clinical Psychiatry. 74(6). 603–613. 167 indexed citations
4.
Zhang, Jianping, Jeffrey J. Weiss, Lawrence Maayan, et al.. (2012). Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders. Journal of Clinical Psychopharmacology. 32(4). 458–464. 10 indexed citations
5.
Manu, Peter, et al.. (2012). Acanthosis Nigricans During Treatment With Aripiprazole. American Journal of Therapeutics. 21(3). e90–e93. 4 indexed citations
6.
Manu, Peter, et al.. (2011). When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophrenia Research. 134(2-3). 180–186. 112 indexed citations
7.
Manu, Peter, Christoph U. Correll, Ruud van Winkel, Martien Wampers, & Marc D. Binder. (2011). Prediabetes in Patients Treated With Antipsychotic Drugs. The Journal of Clinical Psychiatry. 73(4). 460–466. 43 indexed citations
8.
Correll, Christoph U., et al.. (2011). Antipsychotic Drug Administration Does Not Correlate with Prolonged Rate-Corrected QT Interval in Children and Adolescents: Results from a Nested Case–Control Study. Journal of Child and Adolescent Psychopharmacology. 21(4). 365–368. 27 indexed citations
9.
Manu, Peter, James Tsang, Barbara Napolitano, Martin Lesser, & Christoph U. Correll. (2010). Predictors of insulin resistance in the obese with metabolic syndrome. European Journal of Internal Medicine. 21(5). 409–413. 13 indexed citations
10.
Correll, Christoph U., John M. Kane, & Peter Manu. (2010). Obesity and coronary risk in patients treated with second-generation antipsychotics. European Archives of Psychiatry and Clinical Neuroscience. 261(6). 417–423. 24 indexed citations
11.
Kohen, Izchak & Peter Manu. (2010). Rapidly Worsening Hypertriglyceridemia During Treatment with Risperidone. American Journal of Therapeutics. 17(2). 216–218. 5 indexed citations
12.
Kohen, Izchak, et al.. (2008). Antipsychotic-Induced Hyponatremia: Case Report and Literature Review. American Journal of Therapeutics. 15(5). 492–494. 19 indexed citations
13.
Correll, Christoph U., et al.. (2007). Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: Missed targets and lost opportunities. Schizophrenia Research. 92(1-3). 103–107. 14 indexed citations
14.
Correll, Christoph U., Anne M. Frederickson, John M. Kane, & Peter Manu. (2006). Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. The Journal of Clinical Psychiatry. 67(4). 575–583. 166 indexed citations
15.
Manu, Peter, et al.. (1991). Panic Disorder Among Patients With Chronic Fatigue. Southern Medical Journal. 84(4). 451–456. 21 indexed citations
16.
Manu, Peter, Thomas J. Lane, & Dale A. Matthews. (1990). How much practice makes perfect? A quantitative measure of the experience needed to achieve procedural competence. Medical Teacher. 12(3-4). 367–369. 20 indexed citations
17.
Manu, Peter, Thomas J. Lane, Dale A. Matthews, & Javier I. Escobar. (1989). Screening for Somatization Disorder in patients with chronic fatigue. General Hospital Psychiatry. 11(4). 294–297. 7 indexed citations
18.
Calder, Elizabeth A., et al.. (1989). Screening for cancer and coronary risk factors through a nurse practitioner-staffed preventive health clinic. Preventive Medicine. 18(6). 817–823. 6 indexed citations
19.
Manu, Peter, et al.. (1987). OUT-PATIENT USE OF BETA-BLOCKING AGENTS–PRESCRIBING PREFERENCES OF PHYSICIANS IN TRAINING. Journal of Clinical Pharmacy and Therapeutics. 12(6). 409–414. 3 indexed citations
20.
Manu, Peter, et al.. (1985). Analysis of publication output of internal medicine faculty members. Academic Medicine. 60(11). 860–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan M. Meyer Breakdown of academic impact, for papers by Urban Ösby Breakdown of academic impact, for papers by Daniel E. Casey Breakdown of academic impact, for papers by Donna A. Wirshing Breakdown of academic impact, for papers by John Lally Breakdown of academic impact, for papers by Ramy Mahmoud Breakdown of academic impact, for papers by Beverly N. Jones Breakdown of academic impact, for papers by Kim Sweers Breakdown of academic impact, for papers by Heidi Taipale Breakdown of academic impact, for papers by Katja Komossa
Rankless by CCL
2026